Drug Search Results

Lafutidine

Alternative Names: lafutidine
Latest Update: 2023-11-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: H2 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: India | Japan | Korea | Peru

Approved Indications: None

Known Adverse Events: None

Company: Boryung
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Lafutidine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Gastroesophageal Reflux|Esophagitis, Peptic|Esophagitis

Phase 1: Stomach Ulcer|Peptic Ulcer|Gastritis

Trial	Phase	Trial Status	Disease	Primary Completion Date
ChiCTR2200055479	N/A	Recruiting	Gastroesophageal Reflux	2023-06-30
CTR20181930	N/A	Completed	Duodenal Ulcer\|Duodenal Diseases\|Gastritis\|Esophagitis\|Edema	2018-11-16
BR-LIC-CT-101	P1	Completed	Stomach Ulcer	2016-07-01
BR-LAF-CT-101	P1	Completed	Peptic Ulcer	2015-11-01

Recent News Events

Date	Type	Title
11/01/2023	PubMed	A randomized trial to evaluate the preventive effect of lafutidine on chemotherapy-induced peripheral neuropathy in patients treated with carboplatin and paclitaxel for lung cancer.
09/05/2023	PubMed	Ranitidine Use and Incident Cancer in a Multinational Cohort.
01/01/2023	PubMed	Lafutidine Ameliorates Indomethacin-Induced Small Intestinal Damage in Rats by Modifying the Intestinal Mucosal Barrier, Inflammation, and Microbiota.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions